Home / Locations / Bioluminux Clinical Research Wolverhampton
Bioluminux Clinical Research Wolverhampton
About This Site
Our Wolverhampton research site combines experienced clinical research delivery with strong primary care and community connections across Wolverhampton and the wider West Midlands. The site supports Phase 2–4 industry-sponsored clinical trials across multiple therapeutic areas, including cardiovascular and metabolic diseases, respiratory conditions, vaccines and infectious diseases, central nervous system (CNS) disorders, and general medicine.
Through established relationships with local healthcare practices and community partners, the site provides access to diverse patient populations and supports efficient participant identification and enrollment. Our dedicated research team is focused on timely study execution, participant-centered care, protocol compliance, and delivery of reliable, high-quality clinical trial data.
For sponsors and CROs, Wolverhampton offers a responsive, experienced research team with strong local reach and a commitment to meeting study timelines and performance expectations.
Research Leadership
Folashade Nnadozie, BSc, Msc
Site Manager
Specialty:
Dr Philip Nnadozie, MBBS, MRCGP
Site Lead
Specialty: General Pracitioner
Dr Olawale Akinlade, MBBS, MSc, MRCP(UK), FWACP, FACC, FESC, PhD
Physician Investigator/Consultant Cardiologist
Specialty:
Dr Kashini Andrew, MBBS, M.Sc, MRCP(UK)(Edin), MRCP(Dermatology)
Physician Investigator/Consultant Dermatologist
Specialty:
Site Facilities & Amenities
Recruiting Studies At This Location
COPD and Common Colds Research Study
To investigate whether an antiviral medicine can reduce symptoms and COPD flare-ups caused by rhinovirus, a common cold virus.
Hypertension Study
To evaluate whether the investigational treatment reduces the risk of major cardiovascular events in adults with uncontrolled hypertension.
Opioid Dependence Recovery Research Study
To investigate whether adding an investigational medicine to buprenorphine treatment can help reduce opioid use during recovery.